Patents by Inventor Liu Xiuhuai

Liu Xiuhuai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-XL FUSION PROTEIN INHIBITS APOPTOSIS
    Publication number: 20090075882
    Abstract: Apoptosis-modifying fusion polypeptides, and the corresponding nucleic acid molecules, are disclosed. Pharmaceutical compositions comprising these polypeptides, and the use of these polypeptides to modify apoptosis, are also provided.
    Type: Application
    Filed: June 27, 2008
    Publication date: March 19, 2009
    Inventors: Richard J. Youle, Liu Xiuhuai, R. John Collier
  • RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-XL FUSION PROTEIN INHIBITS APOPTOSIS
    Publication number: 20070243190
    Abstract: Apoptosis-modifying fusion polypeptides, and the corresponding nucleic acid molecules, are disclosed. Pharmaceutical compositions comprising these polypeptides, and the use of these polypeptides to modify apoptosis are also provided.
    Type: Application
    Filed: March 27, 2007
    Publication date: October 18, 2007
    Inventors: Richard Youle, Liu Xiuhuai, R. Collier
  • Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis
    Publication number: 20040152179
    Abstract: Apoptosis-modifying fusion polypeptides, and the corresponding nucleic acid molecules, are disclosed. Pharmaceutical compositions comprising these polypeptides, and the use of these polypeptides to modify apoptosis are also provided.
    Type: Application
    Filed: March 2, 2004
    Publication date: August 5, 2004
    Applicant: The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
    Inventors: Richard J. Youle, Liu Xiuhuai, R. John Collier
  • Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
    Patent number: 6737511
    Abstract: Apoptosis-modifying fusion polypeptides, and the corresponding nucleic acid molecules, are disclosed. Pharmaceutical compositions comprising these polypeptides, and the use of these polypeptides to modify apoptosis are also provided.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: May 18, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Richard J. Youle, Liu Xiuhuai, R. John Collier